In recent news, caregivers and healthcare professionals are navigating the complexities surrounding the CDC’s recommendation for COVID-19 vaccination in children aged six months and older. The vaccinations present a crucial preventive measure against the virus. However, uncertainty around the safety and efficacy of vaccines remains prevalent among some sectors.
Cases in point are Pfizer-BioNTech’s three-dose regimen and Moderna’s two-dose vaccination plan tailored for children from six months to four years. Various experts from esteemed institutions like Children’s Hospital Los Angeles have addressed repeated concerns surrounding these vaccinations.
To attest to the efficacy of the vaccine in children, clinical trials have demonstrated sturdy immune responses that are organically equipped to help them ward off COVID-19. The findings have shown the vaccine to prevent severe illness in children as young as six months.
The safety of these vaccinations comes supported by data from Moderna, Pfizer, and the FDA. According to the CDC, vaccines provide a safer, more reliable approach to immunity than contracting and recovering from the virus. The vaccines efficiently decrease the risk of severe disease, hospitalization, and even death. Despite being rare, children can also suffer from long COVID, characterized by a variety of symptoms, such as memory loss, sleep disorders, and muscle weakness. In some rare instances, children can also develop an inflammatory condition named multisystem inflammatory disorder (MIS-C) four to eight weeks post-COVID-19 infection.
Side effects of the vaccine in children were observed to be fatigue, headaches, muscle pain, chills, and occasional fever in clinical trials. The Pfizer-related FDA data showed no cases of myocarditis, a rare heart muscle inflammation occurring in adolescents and young adults, and even more rarely in children under eleven.
When addressing dosage, the vaccination for children aged 5-11 is one-third of the adults and those aged 12 and above. For the youngest age group, Pfizer’s formula is one-tenth the strength of the adult dose, administered in three doses spaced weeks apart. Meanwhile, Moderna’s dose is one-fourth of the adult dose, administered in two shots four weeks apart.
To achieve optimal protection from the virus, similar to adults, a child is considered fully vaccinated two weeks after receiving the final vaccine dosage. Depending on CDC and regional public health recommendations, children should follow safety measures like mask-wearing.
While vaccination reduces the likelihood of infection substantially, it doesn’t completely eradicate the risk of contracting the disease. However, if infected post-vaccination, the symptoms are typically not severe and usually do not require hospitalization.
Post-vaccination, there’s no necessity for a mandatory quarantine. Moreover, the CDC has cleared that simultaneous administration of the COVID-19 and flu vaccines is safe. Vaccines are widely available at pharmacies, pediatrician offices, and children’s hospitals. Patients can check the local public health websites or the California public health portal, MyTurn.ca.gov, to schedule a vaccination appointment at Children’s Hospital Los Angeles.
Source: https://www.newswise.com/articles/kids-and-the-covid-19-vaccine-your-questions-answered